- Staat
- MO
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 04.11.2022
- Impfdatum
- 04.11.2022
- Beginn
- 04.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Symptomtext
PATIENT BRIEFLY PASSED OUT AFTER RECEIVING VACCINES. CAME TO WITHIN 30 SECONDS. EMS WAS CALLED AND CAME AND CHECKED PATIENT AND OK HIM TO LEAVE. NO MEDICATIONS OR ANYTHING WAS GIVEN.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 11.08.2022
- Impfdatum
- 10.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Syncope
Symptomtext
Patient became light headed and fainted
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Unknown
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 20.09.2023
- Impfdatum
- 14.09.2023
- Beginn
- 14.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Fatigue
Headache
Lethargy
Migraine
Pyrexia
Symptomtext
Onset of s/s approx 1800: Migraine, fever 100.5, fatigue, weakness, lethargic. Symptoms persisted throughout the night into next morning. Continues to have daily HA/Migraines without prior hx of HA/migraines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Reports previous adverse events post previous vaccines, but not to this severity.
- Andere Medikamente
- Vitamin B-12, Biotin, Ashwagandha.
- Allergien
- NKA
- Vorherige Impfungen
- Recalls minor HA, lethargy post influenza vaccine 2022. Recalls HA, lethargy, fever, N/V, cold sweats, chills, body aches post c
- Staat
- WY
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 28.02.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Blood creatinine increased
Blood potassium
Blood pressure increased
Chest pain
Computerised tomogram
Deafness
Dizziness
Ear discomfort
Electrocardiogram normal
Eye haemorrhage
Eye pain
Full blood count
Haematocrit
Haemoglobin
Headache
Hypertension
Influenza A virus test negative
Lymphadenopathy
Symptomtext
Pt. said she encountered the following symptoms an hour and half after receiving her 1st adult Hep B, and TST test (in the other arm). She could not say definitively that she'd had the Hep B series as a child: Nausea, dizziness, severe HA, body aches, malaise, bilateral swollen lymph nodes, jaw pain and stiff neck, left eye pain (burst blood vessel in same), blurred vision-left eye, elevated BP-138/88 (normal 90/75), chest pain/"pounding heart", transient pressure in ears with hearing loss. The symptoms have lessened but have not completely gone away. She is still taking acetaminophen/butalbital/caffeine for severe HA.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 2/24/22/Urgent Care: CBC/CMP (slightly elevated Creatinine ,Pot, Hgb, Hct and MCH); 2/25/22/Urgent Care: EKG-normal w/hypertension; covid/flu-neg; 2/25/22ER: EKG; CT w/contrast-normal.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- MTHFR
- Andere Medikamente
- Vit D, Vit C, Fiber, Protein Powder
- Allergien
- Ibu-Stevens-Johnson synd,; stertraline-flushes, diarrhea
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 29.09.2023
- Impfdatum
- 10.08.2023
- Beginn
- 01.08.2023
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Liver function test increased
Urticaria
Symptomtext
Urticaria and elevated LFTs
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 29.09.2023
- Impfdatum
- 10.08.2023
- Beginn
- 01.08.2023
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Liver function test increased
Urticaria
Symptomtext
Urticaria and elevated LFTs
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 19.08.2022
- Impfdatum
- 11.08.2022
- Beginn
- 12.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Back pain
Diarrhoea
Dizziness
Fatigue
Feeling hot
Lip swelling
Nausea
Nodule
Pain
Symptomtext
Received Engerix on 8/11/22. On 8/12/22, began feeling fatigue. on 8/13, began having generalized body aches, diarrhea, light-headed, feeling "hot", nauseated. Felt "nodules" on face with pain to touch, and low back pain. Later in the day, began having bottom lip swelling spreading slightly to top lip.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- Was evaluated in Urgent Care where she was prescribed steroids & atarax
- Aktuelle Erkrankungen
- unknown, but states just completed antibiotic & sudafed treatment for sinus infection just before receiving vaccination
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- allergy to clindamycin
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 05.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 03.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Pain in extremity
Symptomtext
On Wednesday afternoon client started with a sore arm. Late afternoon client reports experiencing some dizziness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none performed at this time.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 13.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
Patient was given HEPATITIS B vaccine in office in his right deltoid. No complaints or concerns until about 30 minutes after immunization. He showed me his right arm and it had 5-6 welps posterior arm and one welps on his left upper arm. No difficulty breathing, swallowing, or shortness of breath noted. Vital signs: 124/84 HR:87 Pulse Ox: 97% on room air Resp:18 No pain Temp: 97.9 oral. Provider evaluated patient and administered benadryl 25mg oral and solumedrol 125mg IM. No complaints noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- n/s
- Aktuelle Erkrankungen
- see below
- Vorgeschichte
- Keratocuonus, bilateral Hyperlipidemia, Vitamin D, Chronic fatigue
- Andere Medikamente
- Prednisolone eye drops Pataday eye drops
- Allergien
- Sulfa drugs
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 29.05.2022
- Impfdatum
- 26.05.2022
- Beginn
- 27.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Peripheral swelling
Symptomtext
patients arm very swollen and painful from prevnar on right arm, left arm with energix b is also swollen and painful
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- undisclosed
- Aktuelle Erkrankungen
- not disclosed
- Vorgeschichte
- not disclosed
- Andere Medikamente
- not disclosed
- Allergien
- not disclosed
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 25.04.2022
- Beginn
- 25.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Rash macular
Urticaria
Symptomtext
Reaction during 15 min wait had blotching, redness and hives start. Treated with: Solumedrol 125 mg IM at 13:40 pm and AT 13:43 Pm Benadryl 50 mg IM per order of FNP All symptoms resolved after medication and patient discharge to home 14:50 with Husband no further complaints (BP 129/77-88-20 and Pulse ox 99%
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash macular
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- March 2022 - entered vaers
- Staat
- TX
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 05.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dysuria
Pyrexia
Symptomtext
This patient states she woke up on 4/5/22 to a fever around 2-3am of 100-101 and states she also experienced painful urination around the same time. This patient states she checked her fever again at 8:30 am on the same day and it went down to 99. This patient states she increased her fluid intake which lessened the painful urination but states the painful urination is still present.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Asthma
- Andere Medikamente
- Takes a multivitamin, prescription antihistamine eye drop, Zyrtec , Tumeric, calcium supplement QD. Singulair and Advair for seasonal allergies prn
- Allergien
- Latex, citrus
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 10.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 10.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
Hives to lower Right and Left hand. No treatment given monitored. No complaints of SOB, dizziness or abnormal CRT.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: unbekannt
Acoustic stimulation tests abnormal
Anxiety
Deafness unilateral
Dizziness
Ear, nose and throat examination abnormal
Eye pain
Hyperacusis
Magnetic resonance imaging head abnormal
Neuritis cranial
Photophobia
Sudden hearing loss
Taste disorder
Tinnitus
VIIIth nerve injury
Vertigo
Vomiting
Symptomtext
01/31/2022 severe tinitus at 11:30 sudden loss of hearing right ear, Lightheaded, dizzy. 02/01/2020 saw ENT specalist Hearing test done, 100% loss of hearing in right ear. Steriod injection done in right ear. 02/01/2022 midnight severe virtigo with vomiting and hypersensitivity to sounds, light, taste, anxiety 02/03/2022 went to Hospital by ambulance 02/04/2022 MRI done, results: neuritis of the 8th cranial nerve. 02/05/2022 left hosptal 02/08/2022 saw ENT specialist, hearing has not come back, virtigo remains, hypersensitivity, right eye pain, severe tinitus. ENT recomends Ophalmology: appointment date 02/16/2022 Nephrology 02/18/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- 3,0
- Labordaten
- Listed in section 18. above 02/01/2020 ENT prescribed 1 gram 3 times a day for a week of Valcyclovir and 60 Mg of steroid. Hospital was given steroids, meclizine, valium and pain medication. Was told to finish prescribed medication from ENT specialist and follow up with him.
- Aktuelle Erkrankungen
- Tested postive for covid on 01/06/2022
- Vorgeschichte
- Post kidney transplant recipient 06/06/2019 Tested positive for Covid 11/10/2020
- Andere Medikamente
- Levithroxine 150 MG daily/ Evarsus Extended Release 4 MG daily Myfortic 180 MG three pills twice dality prednisone 5 Mg daily Valcyclvir 500 Mg daily Gabapentin 200 Mg daily Cinaccalet 30 Mg daily melitonin 10-40 Mg as needed
- Allergien
- Codine
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 27.12.2023
- Impfdatum
- 19.12.2023
- Beginn
- 19.12.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
patient was administered a dose of Engerix-B on 19FDec2023 which had an expiration date of 03Dec2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 49-year-old female patient who received HBV (Engerix B) (batch number TB3KN, expiry date 03-DEC-2023) for prophylaxis. On 19-DEC-2023, the patient received the 2nd dose of Engerix B. On 19-DEC-2023, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: patient was administered a dose of Engerix-B on 19FDec2023 which had an expiration date of 03Dec2023). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-DEC-2023 The nurse reported that a patient was administered a dose of Engerix-B which was already expired. At the time of reporting, the dose had not been repeated. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. This case had been link with US2023177289, reported by the same reporter.; Sender's Comments: US-GSK-US2023177289:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 09.08.2023
- Impfdatum
- 18.07.2023
- Beginn
- 01.07.2023
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No adverse event reported to facility, however patient given Engerix-B indicated for 20 years old and older but patient 17 years old at time of vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 23.06.2023
- Impfdatum
- 07.01.2023
- Beginn
- 07.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
There was NO adverse event reported. The patient presented to the pharmacy requesting a second vaccine of HepB. It was determined she was given Engerix-B 20mcg/ml indicated for 20 years and up. She was 19 at the time of administration on 1-7-2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- na
- Aktuelle Erkrankungen
- na
- Vorgeschichte
- na
- Andere Medikamente
- na
- Allergien
- na
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 0,8
- Geschlecht
- M
- Eingang
- 12.06.2023
- Impfdatum
- 12.06.2023
- Beginn
- 12.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
No adverse event
Symptomtext
Patient received the HepB Adult dose instead of the HepB pediatric dose. As of 5:20pm 6/12/2023 patient had not had any adverse effects according to patient's father.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 03.04.2023
- Impfdatum
- 17.03.2022
- Beginn
- 19.03.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Immunisation reaction
Symptomtext
Adverse effect of other vaccines and biological substances, initial encounter on 2022-03-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immunisation reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Encounter for screening for diabetes mellitus; Encounter for screening for cholesterol level; Type 2 diabetes mellitus without complications; Obstructive sleep apnea (adult) (pediatric); high blood pressure; Post-acute sequela of COVID-19; Other chest pain; Body mass index [BMI] 34.0-34.9, adult; Perioral dermatitis; rash NOS; Body mass index [BMI] 35.0-35.9, adult; Hypothyroidism, unspecified; Type 2 diabetes mellitus without complications; Vitamin D deficiency, unspecified; Adjustment disorder with depressed mood; Obstructive sleep apnea (adult) (pediatric); high blood pressure; Chest pain, unspecified; Encounter for adult health check-up NOS; Added by load_epic.py; Adjustment disorder with depressed mood; Post-acute sequela of COVID-19; Hypothyroidism, unspecified; Type 2 diabetes mellitus without complications; high blood pressure; Encounter for adult health check-up NOS; Lipoma NOS; Hypothyroidism, unspecified; Type 2 diabetes mellitus without complications; Obstructive sleep apnea (adult) (pediatric); high blood pressure; Chest pain, unspecified; Post-acute sequela of COVID-19; Encounter for adult health check-up NOS; Encounter for screening for malignant neoplasm of colon; Encounter for screening mammogram for malignant neoplasm of breast; Body mass index [BMI] 35.0-35.9, adult
- Vorgeschichte
- -
- Andere Medikamente
- ADULT BLOOD PRESSURE CUFF LG KIT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 23,0
- Geschlecht
- M
- Eingang
- 22.02.2023
- Impfdatum
- 09.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 22.02.2023
- Impfdatum
- 27.07.2022
- Beginn
- 22.02.2023
- Tage bis Beginn
- 210,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 22.02.2023
- Impfdatum
- 22.08.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 22.02.2023
- Impfdatum
- 22.08.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 22.02.2023
- Impfdatum
- 09.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 21.02.2023
- Impfdatum
- 29.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- NAFLD, Rheumatoid arthritis, Type 2 diabetes
- Andere Medikamente
- Prescriptions: atorvastatin 10 mg oral tablet: 1 tab(s) Oral Daily chlorthalidone 25 mg oral tablet: 1 tab(s) Oral Daily Humira Pen 40 mg/0.4 mL subcutaneous kit (adalimumab): 0.4 mL Subcutaneous Every 2 Weeks hydrocortis
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- -
- Geschlecht
- F
- Eingang
- 03.12.2022
- Impfdatum
- 23.11.2022
- Beginn
- 23.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Product administered to patient of inappropriate age
Symptomtext
20 mcg dose administered to a 14-year-old; 20 mcg dose administered instead of a 10 mcg; This case was reported by a pharmacist via call center representative and described the occurrence of overdose in a 14-year-old female patient who received HBV (Engerix B adult) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis. On 23rd November 2022, the patient received the 1st dose of Engerix B adult 20 ?g. On 23rd November 2022, unknown after receiving Engerix B adult, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown. Additional Information: GSK receipt date: 23-Nov-2022 Reporter's comment: The dose administrated was 20 mcg not 10 mcg dose. The vaccine administration facility was the same as primary reporter. The reporter agreed to follow-up. Additional supportive information: A dose of Engerix-B vaccine (20 mcg) had been administered to a patient of inappropriate age, which led to overdose and adult product administered to child.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,5
- Geschlecht
- M
- Eingang
- 19.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Product administered to patient of inappropriate age
Symptomtext
6 month old received an adult dose; 6 month old received an adult dose; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 6-month-old male patient who received HBV (Engerix B adult) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis. On 10th October 2022, the patient received the 3rd dose of Engerix B adult. On 10th October 2022, unknown after receiving Engerix B adult, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown. Additional Information: GSK Receipt Date: 10-Oct-2022 Reporter's comment: A nurse reported that the patient received an adult 1 ml dose of Engerix. No symptoms were reported. The reporter consented to follow up. Additional Supportive Information: The 6 months old patient received an adult 1 ml dose of Engerix, which led to overdose and adult product administered to child.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 09.08.2022
- Impfdatum
- 01.08.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental overdose
Extra dose administered
Product administered to patient of inappropriate age
Symptomtext
5 YO wasgiven adult dose; 5 YO wasgiven adult dose; 5 YO wasgiven 4th dose; This case was reported by a nurse via call center representative and described the occurrence of accidental overdose in a 5-year-old male patient who received HBV (Engerix B adult) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 1st August 2022, the patient received the 4th dose of Engerix B adult 1 ml and Engerix B Pre-Filled Syringe Device. On 1st August 2022, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced accidental overdose, adult product administered to child and extra dose administered. On an unknown date, the outcome of the accidental overdose, adult product administered to child and extra dose administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 3-Aug-2022 Reporter's comment: The patient was accidentally given an adult dose of Engerix-B for his fourth dose at age of 5 years. The reporter did'nt had anything else to report. The reporter consented to follow up. Additional supportive information: The patient received an adult dose of Engerix B at age of 5 years, which led to the accidental overdose and adult product administered to child. The patient received fourth dose of Engerix B at age of 5 years, which led to Extra dose administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 01.12.2002
- Beginn
- 01.12.2002
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Inappropriate schedule of product administration
Symptomtext
received Engerix-B 4th dose; third dose 7/14/2020, first and second Oct 2002 and Dic 2002 respectively; third dose 7/14/2020, first and second Oct 2002 and Dic 2002 respectively; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 17-year-old female patient who received HBV (Engerix B) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis. Co-suspect products included HBV (Engerix B) for prophylaxis and HBV (Engerix B) for prophylaxis. Previously administered products included Engerix-B (received 1st dose in October 2002). On 30th June 2022, the patient received the 4th dose of Engerix B. On 14th July 2020, the patient received the 3rd dose of Engerix B. In December 2002, the patient received the 2nd dose of Engerix B. In December 2002, unknown after receiving Engerix B, the patient experienced drug dose administration interval too long. On 14th July 2020, the patient experienced drug dose administration interval too long. On 30th June 2022, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered, drug dose administration interval too long and drug dose administration interval too long were unknown. Additional Information: GSK receipt date: 01-Aug-2022 Reporter's comment: The nurse reported that they had two patients received Engerix-B extra dose by error. The reporter consented to follow-up via email. The case is for 2 of 2 linked patients, reported by same reporter. Additional supportive information: The patient received the 2nd and 3rd dose of Engerix-B later than the recommended interval, which led to lengthening of vaccine schedule. The patient also received 4th dose of Engerix-B, which led to extra dose administered. As the patient received an extra dose of Engerix-B and it was clear that the dose was given by error and intention behind the dose giving was unknown therefore extra dose administered event was coded.; Sender's Comments: US-GSK-US2022113816:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
received extra dose by error; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 22-year-old male patient who received HBV (Engerix B) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis. On 29th July 2022, the patient received the 4th dose of Engerix B. On 29th July 2022, unknown after receiving Engerix B, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. Additional Information: GSK receipt date: 01-Aug-2022 Reporter's comment: The nurse had two adult patients that received Engerix-B extra dose by error. The reporter consented to follow-up via email. This case is for 1 of 2 linked patients, reported by same reporter. Additional supportive information: The patient received an extra dose of Engerix-B, which led to extra dose administered. As there is no information regarding the primary vaccination of Engerix therefore Extra dose administered event coded as it was clearly stated by error dose was administered and for the primary vaccination details follow-up query was raised.; Sender's Comments: US-GSK-US2022113819:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Temperature excursion 46.2 degree celsius; This case was reported by a consumer via other manufacturer and described the occurrence of incorrect storage of drug in a patient who received HBV (Engerix B) (batch number TB3KN, expiry date unknown) for prophylaxis. Co-suspect products included HAV (Havrix) (batch number 7YA99, expiry date unknown) for prophylaxis. On an unknown date, the patient received Engerix B and Havrix. On an unknown date, unknown after receiving Engerix B and Havrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional Information: GSK Receipt Date: 28-Jul-2022 Reporter's Comments: The reporter stated that they had temperature excursion last night it went from a temperature of 46.2 degree Celsius at 7:14, at 9 o clock temperature went back to normal. It was unknown if the vaccine was administered to any patient. The reporter wanted to know if the vaccine still ok. Additional supportive Information: The Havrix and Engerix B stored at temperature of 46.2 degree Celsius, which leads to Incorrect storage of drug.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 30.06.2022
- Impfdatum
- 27.06.2022
- Beginn
- 27.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Electrocardiogram
Immunisation reaction
Laboratory test
Symptomtext
Done in Health: Benadryl 25mg tablet, Epi 0.3mg IM, Sent ER. ER per patient: Liquid Benadryl, Fluids, Labs and EKG
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Electrocardiogram
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- N/A
- Andere Medikamente
- None
- Allergien
- Laundry detergent
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 23.06.2022
- Impfdatum
- 10.06.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect route of product administration
No adverse event
Symptomtext
IM injection given SC route. patient was observed for 45 minutes; no adverse event occurred;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- F
- Eingang
- 22.06.2022
- Impfdatum
- 20.06.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
I unintentionally administered a Hepatitis A vaccine that expired on 6/18/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 25.05.2022
- Beginn
- 25.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Symptomtext
received 3 doses on 25-MAY-2022; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 51-year-old female patient who received HBV (Engerix B adult) (batch number tb3kn, expiry date 3rd December 2023) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B adult) (batch number tb3kn, expiry date unknown) for prophylaxis, hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B adult) (batch number tb3kn, expiry date 3rd December 2023) for prophylaxis and hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 25th May 2022, the patient received Engerix B adult (intramuscular) .5 ml, Engerix B Pre-Filled Syringe Device, Engerix B adult (intramuscular) .5 ml, Engerix B Pre-Filled Syringe Device, Engerix B adult (intramuscular) .5 ml and Engerix B Pre-Filled Syringe Device. On 25th May 2022, unknown after receiving Engerix B adult, Engerix B Pre-Filled Syringe Device, Engerix B adult, Engerix B Pre-Filled Syringe Device, Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 27 May 2022 Reporter's comment: The reporter was an administrator for a clinic who reported that a patient received 3 doses of Engerix B on same day. The reporter consented to follow up. Additional Supportive Information: The patient received 3 doses of Engerix B on same day which led to overdose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 18.05.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
incorrect vaccine administered.Boostrix was erroneously given instead of Engerix
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- na
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- F
- Eingang
- 06.05.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
received dose of engerix-b only two weeks after the 1st dose; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a adult female patient who received HBV (Engerix B) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included HEPATITIS B VACCINE (ENGERIX B). On an unknown date, the patient received the 2nd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device and an unknown time after receiving ENGERIX B, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 26-APR-2022 Reporter's Comments: The reporter stated that patient received the second dose of Engerix B only two weeks after 1st dose. The reporter gave consent for a follow-up. Additional Supportive Information: The patient received the second dose of Engerix b only two weeks after 1st dose, which led to Drug dose administration interval too short.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ENGERIX B
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 08.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Overdose
Product administered to patient of inappropriate age
Symptomtext
19-year-old patient received an adult dose; 19-year-old patient received an adult dose; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 19-year-old female patient who received HBV (Engerix B adult) (batch number TB3KN, expiry date unknown) for prophylaxis. On 4th April 2022, the patient received Engerix B adult. On 4th April 2022, unknown after receiving Engerix B adult, the patient experienced overdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the overdose and inappropriate age at vaccine administration were unknown. Additional Information: GSK receipt date: 05-Apr-2022 Reporter's comment: Nurse reported that a patient received an adult dose of Engerix-B, which led to overdose and inappropriate age of vaccine administration. The reporter consented to follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 30.03.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
HIV test
Hepatitis viral test
Needle issue
Symptomtext
ASSOCIATE HAD A FINGER STICK AFTER VACCINATING A PATIENT. ASSOCIATE WAS TRYING TO ENGAGE SAFETY COVER OVER USED NEEDLE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- HIV test
- Hospital-Tage
- -
- Labordaten
- ASSOCIATE (PHARMACIST) WHO HAD BEEN GRAZED WITH NEEDLE WENT TO A LAB FOR HEPATITIS AND HIV TESTING. SO DID THE PATIENT WHO WAS VACCINATED.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 16.03.2022
- Impfdatum
- 14.03.2022
- Beginn
- 14.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Symptomtext
10 min after injections there was a localized reaction of redness noted on both arms, more on right side. Pt denied SOB, chest tightness, throat swelling. 50mg benadryl and 125mg Solu-Medrol given. Patient began feeling better and was discharged home with instructions if further difficulty.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- na
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- na
- Allergien
- na
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 23.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Product administered to patient of inappropriate age
Product preparation issue
Symptomtext
Patient was given adult formulation of Energix B instead of pediatric dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -